- Home
- SYRE vs EQBK Comparison
SYRE vs EQBK Comparison
Compare SYRE & EQBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SYRE
- EQBK
- Stock Information
- Founded
- SYRE 2013
- EQBK 2002
- Country
- SYRE United States
- EQBK United States
- Employees
- SYRE N/A
- EQBK N/A
- Industry
- SYRE Biotechnology: Pharmaceutical Preparations
- EQBK Major Banks
- Sector
- SYRE Health Care
- EQBK Finance
- Exchange
- SYRE Nasdaq
- EQBK Nasdaq
- Market Cap
- SYRE 841.4M
- EQBK 673.9M
- IPO Year
- SYRE 2016
- EQBK 2015
- Fundamental
- Price
- SYRE $15.30
- EQBK $38.86
- Analyst Decision
- SYRE Buy
- EQBK Hold
- Analyst Count
- SYRE 6
- EQBK 6
- Target Price
- SYRE $55.00
- EQBK $44.20
- AVG Volume (30 Days)
- SYRE 490.0K
- EQBK 43.1K
- Earning Date
- SYRE 05-08-2025
- EQBK 07-15-2025
- Dividend Yield
- SYRE N/A
- EQBK 1.54%
- EPS Growth
- SYRE N/A
- EQBK 543.37
- EPS
- SYRE N/A
- EQBK 3.93
- Revenue
- SYRE N/A
- EQBK $224,743,000.00
- Revenue This Year
- SYRE N/A
- EQBK $20.11
- Revenue Next Year
- SYRE N/A
- EQBK $10.81
- P/E Ratio
- SYRE N/A
- EQBK $9.90
- Revenue Growth
- SYRE N/A
- EQBK 56.39
- 52 Week Low
- SYRE $10.91
- EQBK $32.24
- 52 Week High
- SYRE $40.26
- EQBK $50.85
- Technical
- Relative Strength Index (RSI)
- SYRE 51.16
- EQBK 46.14
- Support Level
- SYRE $14.87
- EQBK $38.59
- Resistance Level
- SYRE $15.71
- EQBK $39.49
- Average True Range (ATR)
- SYRE 0.72
- EQBK 0.68
- MACD
- SYRE 0.10
- EQBK -0.21
- Stochastic Oscillator
- SYRE 51.57
- EQBK 17.26
About SYRE Spyre Therapeutics Inc.
Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.
About EQBK Equity Bancshares Inc.
Equity Bancshares Inc is a bank holding company. It provides a broad range of financial services to businesses and business owners as well as individuals through network of nearly 71 branches located in Arkansas, Kansas, Missouri and Oklahoma. The majority of the Company's revenues come from interest income on financial instruments, including loans, leases, securities and derivatives. The company also earns revenue from Non-interest income which includes Service charges and fees, Debit card income, Investment Referral Income, Trust Income and Insurance Sales Commissions.